0
     

Report Added
Report already added
Anthrax Vaccines Market - Global Outlook and Forecast 2021-2027

Anthrax Vaccines Market - Global Outlook and Forecast 2021-2027

This report contains market size and forecasts of Anthrax Vaccines in global, including the following market information:
Global Anthrax Vaccines Market Revenue, 2016-2021, 2022-2027, ($ millions)
Global Anthrax Vaccines Market Sales, 2016-2021, 2022-2027, (M Doses)
Global top five Anthrax Vaccines companies in 2020 (%)
The global Anthrax Vaccines market was valued at 653.4 million in 2020 and is projected to reach US$ 865.2 million by 2027, at a CAGR of 7.3% during the forecast period.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Anthrax Vaccines manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Anthrax Vaccines Market, By Type, 2016-2021, 2022-2027 ($ Millions) & (M Doses)
Global Anthrax Vaccines Market Segment Percentages, By Type, 2020 (%)
Live Vaccines
Cell free PA Vaccines

Global Anthrax Vaccines Market, By Application, 2016-2021, 2022-2027 ($ Millions) & (M Doses)
Global Anthrax Vaccines Market Segment Percentages, By Application, 2020 (%)
Human Use
Animal Use

Global Anthrax Vaccines Market, By Region and Country, 2016-2021, 2022-2027 ($ Millions) & (M Doses)
Global Anthrax Vaccines Market Segment Percentages, By Region and Country, 2020 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa

Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Anthrax Vaccines revenues in global market, 2016-2021 (Estimated), ($ millions)
Key companies Anthrax Vaccines revenues share in global market, 2020 (%)
Key companies Anthrax Vaccines sales in global market, 2016-2021 (Estimated), (M Doses)
Key companies Anthrax Vaccines sales share in global market, 2020 (%)
Further, the report presents profiles of competitors in the market, key players include:
Emergent BioSolutions
Merial
Merck
Zoetis
Bayer Sanidad Animal
Colorado Serum
PharmAthene
Tiankang
Biogénesis-Bago
CAVAC
Rosenbusch
Agrovet
Vecol
CVCRI
IVPM
Prondil
CDV
Indian Immunologicals
Botswana Vaccine Institute
Ceva Santé Animale
Intervac
JOVAC
1 Introduction to Research & Analysis Reports
1.1 Anthrax Vaccines Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Anthrax Vaccines Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Anthrax Vaccines Overall Market Size
2.1 Global Anthrax Vaccines Market Size: 2021 VS 2027
2.2 Global Anthrax Vaccines Revenue, Prospects & Forecasts: 2016-2027
2.3 Global Anthrax Vaccines Sales (Consumption): 2016-2027
3 Company Landscape
3.1 Top Anthrax Vaccines Players in Global Market
3.2 Top Global Anthrax Vaccines Companies Ranked by Revenue
3.3 Global Anthrax Vaccines Revenue by Companies
3.4 Global Anthrax Vaccines Sales by Companies
3.5 Global Anthrax Vaccines Price by Manufacturer (2016-2021)
3.6 Top 3 and Top 5 Anthrax Vaccines Companies in Global Market, by Revenue in 2020
3.7 Global Manufacturers Anthrax Vaccines Product Type
3.8 Tier 1, Tier 2 and Tier 3 Anthrax Vaccines Players in Global Market
3.8.1 List of Global Tier 1 Anthrax Vaccines Companies
3.8.2 List of Global Tier 2 and Tier 3 Anthrax Vaccines Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Anthrax Vaccines Market Size Markets, 2021 & 2027
4.1.2 Live Vaccines
4.1.3 Cell free PA Vaccines
4.2 By Type - Global Anthrax Vaccines Revenue & Forecasts
4.2.1 By Type - Global Anthrax Vaccines Revenue, 2016-2021
4.2.2 By Type - Global Anthrax Vaccines Revenue, 2022-2027
4.2.3 By Type - Global Anthrax Vaccines Revenue Market Share, 2016-2027
4.3 By Type - Global Anthrax Vaccines Sales & Forecasts
4.3.1 By Type - Global Anthrax Vaccines Sales, 2016-2021
4.3.2 By Type - Global Anthrax Vaccines Sales, 2022-2027
4.3.3 By Type - Global Anthrax Vaccines Sales Market Share, 2016-2027
4.4 By Type - Global Anthrax Vaccines Price (Manufacturers Selling Prices), 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Anthrax Vaccines Market Size, 2021 & 2027
5.1.2 Human Use
5.1.3 Animal Use
5.2 By Application - Global Anthrax Vaccines Revenue & Forecasts
5.2.1 By Application - Global Anthrax Vaccines Revenue, 2016-2021
5.2.2 By Application - Global Anthrax Vaccines Revenue, 2022-2027
5.2.3 By Application - Global Anthrax Vaccines Revenue Market Share, 2016-2027
5.3 By Application - Global Anthrax Vaccines Sales & Forecasts
5.3.1 By Application - Global Anthrax Vaccines Sales, 2016-2021
5.3.2 By Application - Global Anthrax Vaccines Sales, 2022-2027
5.3.3 By Application - Global Anthrax Vaccines Sales Market Share, 2016-2027
5.4 By Application - Global Anthrax Vaccines Price (Manufacturers Selling Prices), 2016-2027
6 Sights by Region
6.1 By Region - Global Anthrax Vaccines Market Size, 2021 & 2027
6.2 By Region - Global Anthrax Vaccines Revenue & Forecasts
6.2.1 By Region - Global Anthrax Vaccines Revenue, 2016-2021
6.2.2 By Region - Global Anthrax Vaccines Revenue, 2022-2027
6.2.3 By Region - Global Anthrax Vaccines Revenue Market Share, 2016-2027
6.3 By Region - Global Anthrax Vaccines Sales & Forecasts
6.3.1 By Region - Global Anthrax Vaccines Sales, 2016-2021
6.3.2 By Region - Global Anthrax Vaccines Sales, 2022-2027
6.3.3 By Region - Global Anthrax Vaccines Sales Market Share, 2016-2027
6.4 North America
6.4.1 By Country - North America Anthrax Vaccines Revenue, 2016-2027
6.4.2 By Country - North America Anthrax Vaccines Sales, 2016-2027
6.4.3 US Anthrax Vaccines Market Size, 2016-2027
6.4.4 Canada Anthrax Vaccines Market Size, 2016-2027
6.4.5 Mexico Anthrax Vaccines Market Size, 2016-2027
6.5 Europe
6.5.1 By Country - Europe Anthrax Vaccines Revenue, 2016-2027
6.5.2 By Country - Europe Anthrax Vaccines Sales, 2016-2027
6.5.3 Germany Anthrax Vaccines Market Size, 2016-2027
6.5.4 France Anthrax Vaccines Market Size, 2016-2027
6.5.5 U.K. Anthrax Vaccines Market Size, 2016-2027
6.5.6 Italy Anthrax Vaccines Market Size, 2016-2027
6.5.7 Russia Anthrax Vaccines Market Size, 2016-2027
6.5.8 Nordic Countries Anthrax Vaccines Market Size, 2016-2027
6.5.9 Benelux Anthrax Vaccines Market Size, 2016-2027
6.6 Asia
6.6.1 By Region - Asia Anthrax Vaccines Revenue, 2016-2027
6.6.2 By Region - Asia Anthrax Vaccines Sales, 2016-2027
6.6.3 China Anthrax Vaccines Market Size, 2016-2027
6.6.4 Japan Anthrax Vaccines Market Size, 2016-2027
6.6.5 South Korea Anthrax Vaccines Market Size, 2016-2027
6.6.6 Southeast Asia Anthrax Vaccines Market Size, 2016-2027
6.6.7 India Anthrax Vaccines Market Size, 2016-2027
6.7 South America
6.7.1 By Country - South America Anthrax Vaccines Revenue, 2016-2027
6.7.2 By Country - South America Anthrax Vaccines Sales, 2016-2027
6.7.3 Brazil Anthrax Vaccines Market Size, 2016-2027
6.7.4 Argentina Anthrax Vaccines Market Size, 2016-2027
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Anthrax Vaccines Revenue, 2016-2027
6.8.2 By Country - Middle East & Africa Anthrax Vaccines Sales, 2016-2027
6.8.3 Turkey Anthrax Vaccines Market Size, 2016-2027
6.8.4 Israel Anthrax Vaccines Market Size, 2016-2027
6.8.5 Saudi Arabia Anthrax Vaccines Market Size, 2016-2027
6.8.6 UAE Anthrax Vaccines Market Size, 2016-2027
7 Manufacturers & Brands Profiles
7.1 Emergent BioSolutions
7.1.1 Emergent BioSolutions Corporate Summary
7.1.2 Emergent BioSolutions Business Overview
7.1.3 Emergent BioSolutions Anthrax Vaccines Major Product Offerings
7.1.4 Emergent BioSolutions Anthrax Vaccines Sales and Revenue in Global (2016-2021)
7.1.5 Emergent BioSolutions Key News
7.2 Merial
7.2.1 Merial Corporate Summary
7.2.2 Merial Business Overview
7.2.3 Merial Anthrax Vaccines Major Product Offerings
7.2.4 Merial Anthrax Vaccines Sales and Revenue in Global (2016-2021)
7.2.5 Merial Key News
7.3 Merck
7.3.1 Merck Corporate Summary
7.3.2 Merck Business Overview
7.3.3 Merck Anthrax Vaccines Major Product Offerings
7.3.4 Merck Anthrax Vaccines Sales and Revenue in Global (2016-2021)
7.3.5 Merck Key News
7.4 Zoetis
7.4.1 Zoetis Corporate Summary
7.4.2 Zoetis Business Overview
7.4.3 Zoetis Anthrax Vaccines Major Product Offerings
7.4.4 Zoetis Anthrax Vaccines Sales and Revenue in Global (2016-2021)
7.4.5 Zoetis Key News
7.5 Bayer Sanidad Animal
7.5.1 Bayer Sanidad Animal Corporate Summary
7.5.2 Bayer Sanidad Animal Business Overview
7.5.3 Bayer Sanidad Animal Anthrax Vaccines Major Product Offerings
7.5.4 Bayer Sanidad Animal Anthrax Vaccines Sales and Revenue in Global (2016-2021)
7.5.5 Bayer Sanidad Animal Key News
7.6 Colorado Serum
7.6.1 Colorado Serum Corporate Summary
7.6.2 Colorado Serum Business Overview
7.6.3 Colorado Serum Anthrax Vaccines Major Product Offerings
7.6.4 Colorado Serum Anthrax Vaccines Sales and Revenue in Global (2016-2021)
7.6.5 Colorado Serum Key News
7.7 PharmAthene
7.7.1 PharmAthene Corporate Summary
7.7.2 PharmAthene Business Overview
7.7.3 PharmAthene Anthrax Vaccines Major Product Offerings
7.4.4 PharmAthene Anthrax Vaccines Sales and Revenue in Global (2016-2021)
7.7.5 PharmAthene Key News
7.8 Tiankang
7.8.1 Tiankang Corporate Summary
7.8.2 Tiankang Business Overview
7.8.3 Tiankang Anthrax Vaccines Major Product Offerings
7.8.4 Tiankang Anthrax Vaccines Sales and Revenue in Global (2016-2021)
7.8.5 Tiankang Key News
7.9 Biogénesis-Bago
7.9.1 Biogénesis-Bago Corporate Summary
7.9.2 Biogénesis-Bago Business Overview
7.9.3 Biogénesis-Bago Anthrax Vaccines Major Product Offerings
7.9.4 Biogénesis-Bago Anthrax Vaccines Sales and Revenue in Global (2016-2021)
7.9.5 Biogénesis-Bago Key News
7.10 CAVAC
7.10.1 CAVAC Corporate Summary
7.10.2 CAVAC Business Overview
7.10.3 CAVAC Anthrax Vaccines Major Product Offerings
7.10.4 CAVAC Anthrax Vaccines Sales and Revenue in Global (2016-2021)
7.10.5 CAVAC Key News
7.11 Rosenbusch
7.11.1 Rosenbusch Corporate Summary
7.11.2 Rosenbusch Anthrax Vaccines Business Overview
7.11.3 Rosenbusch Anthrax Vaccines Major Product Offerings
7.11.4 Rosenbusch Anthrax Vaccines Sales and Revenue in Global (2016-2021)
7.11.5 Rosenbusch Key News
7.12 Agrovet
7.12.1 Agrovet Corporate Summary
7.12.2 Agrovet Anthrax Vaccines Business Overview
7.12.3 Agrovet Anthrax Vaccines Major Product Offerings
7.12.4 Agrovet Anthrax Vaccines Sales and Revenue in Global (2016-2021)
7.12.5 Agrovet Key News
7.13 Vecol
7.13.1 Vecol Corporate Summary
7.13.2 Vecol Anthrax Vaccines Business Overview
7.13.3 Vecol Anthrax Vaccines Major Product Offerings
7.13.4 Vecol Anthrax Vaccines Sales and Revenue in Global (2016-2021)
7.13.5 Vecol Key News
7.14 CVCRI
7.14.1 CVCRI Corporate Summary
7.14.2 CVCRI Business Overview
7.14.3 CVCRI Anthrax Vaccines Major Product Offerings
7.14.4 CVCRI Anthrax Vaccines Sales and Revenue in Global (2016-2021)
7.14.5 CVCRI Key News
7.15 IVPM
7.15.1 IVPM Corporate Summary
7.15.2 IVPM Business Overview
7.15.3 IVPM Anthrax Vaccines Major Product Offerings
7.15.4 IVPM Anthrax Vaccines Sales and Revenue in Global (2016-2021)
7.15.5 IVPM Key News
7.16 Prondil
7.16.1 Prondil Corporate Summary
7.16.2 Prondil Business Overview
7.16.3 Prondil Anthrax Vaccines Major Product Offerings
7.16.4 Prondil Anthrax Vaccines Sales and Revenue in Global (2016-2021)
7.16.5 Prondil Key News
7.17 CDV
7.17.1 CDV Corporate Summary
7.17.2 CDV Business Overview
7.17.3 CDV Anthrax Vaccines Major Product Offerings
7.17.4 CDV Anthrax Vaccines Sales and Revenue in Global (2016-2021)
7.17.5 CDV Key News
7.18 Indian Immunologicals
7.18.1 Indian Immunologicals Corporate Summary
7.18.2 Indian Immunologicals Business Overview
7.18.3 Indian Immunologicals Anthrax Vaccines Major Product Offerings
7.18.4 Indian Immunologicals Anthrax Vaccines Sales and Revenue in Global (2016-2021)
7.18.5 Indian Immunologicals Key News
7.19 Botswana Vaccine Institute
7.19.1 Botswana Vaccine Institute Corporate Summary
7.19.2 Botswana Vaccine Institute Business Overview
7.19.3 Botswana Vaccine Institute Anthrax Vaccines Major Product Offerings
7.19.4 Botswana Vaccine Institute Anthrax Vaccines Sales and Revenue in Global (2016-2021)
7.19.5 Botswana Vaccine Institute Key News
7.20 Ceva Santé Animale
7.20.1 Ceva Santé Animale Corporate Summary
7.20.2 Ceva Santé Animale Business Overview
7.20.3 Ceva Santé Animale Anthrax Vaccines Major Product Offerings
7.20.4 Ceva Santé Animale Anthrax Vaccines Sales and Revenue in Global (2016-2021)
7.20.5 Ceva Santé Animale Key News
7.21 Intervac
7.21.1 Intervac Corporate Summary
7.21.2 Intervac Business Overview
7.21.3 Intervac Anthrax Vaccines Major Product Offerings
7.21.4 Intervac Anthrax Vaccines Sales and Revenue in Global (2016-2021)
7.21.5 Intervac Key News
7.22 JOVAC
7.22.1 JOVAC Corporate Summary
7.22.2 JOVAC Business Overview
7.22.3 JOVAC Anthrax Vaccines Major Product Offerings
7.22.4 JOVAC Anthrax Vaccines Sales and Revenue in Global (2016-2021)
7.22.5 JOVAC Key News
8 Global Anthrax Vaccines Production Capacity, Analysis
8.1 Global Anthrax Vaccines Production Capacity, 2016-2027
8.2 Anthrax Vaccines Production Capacity of Key Manufacturers in Global Market
8.3 Global Anthrax Vaccines Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Anthrax Vaccines Supply Chain Analysis
10.1 Anthrax Vaccines Industry Value Chain
10.2 Anthrax Vaccines Upstream Market
10.3 Anthrax Vaccines Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Anthrax Vaccines Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List of Tables
Table 1. Key Players of Anthrax Vaccines in Global Market
Table 2. Top Anthrax Vaccines Players in Global Market, Ranking by Revenue (2019)
Table 3. Global Anthrax Vaccines Revenue by Companies, (US$, Mn), 2016-2021
Table 4. Global Anthrax Vaccines Revenue Share by Companies, 2016-2021
Table 5. Global Anthrax Vaccines Sales by Companies, (M Doses), 2016-2021
Table 6. Global Anthrax Vaccines Sales Share by Companies, 2016-2021
Table 7. Key Manufacturers Anthrax Vaccines Price (2016-2021) & (USD/K Doses)
Table 8. Global Manufacturers Anthrax Vaccines Product Type
Table 9. List of Global Tier 1 Anthrax Vaccines Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Anthrax Vaccines Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type – Global Anthrax Vaccines Revenue, (US$, Mn), 2021 VS 2027
Table 12. By Type - Global Anthrax Vaccines Revenue (US$, Mn), 2016-2021
Table 13. By Type - Global Anthrax Vaccines Revenue (US$, Mn), 2022-2027
Table 14. By Type - Global Anthrax Vaccines Sales (M Doses), 2016-2021
Table 15. By Type - Global Anthrax Vaccines Sales (M Doses), 2022-2027
Table 16. By Application – Global Anthrax Vaccines Revenue, (US$, Mn), 2021 VS 2027
Table 17. By Application - Global Anthrax Vaccines Revenue (US$, Mn), 2016-2021
Table 18. By Application - Global Anthrax Vaccines Revenue (US$, Mn), 2022-2027
Table 19. By Application - Global Anthrax Vaccines Sales (M Doses), 2016-2021
Table 20. By Application - Global Anthrax Vaccines Sales (M Doses), 2022-2027
Table 21. By Region – Global Anthrax Vaccines Revenue, (US$, Mn), 2021 VS 2027
Table 22. By Region - Global Anthrax Vaccines Revenue (US$, Mn), 2016-2021
Table 23. By Region - Global Anthrax Vaccines Revenue (US$, Mn), 2022-2027
Table 24. By Region - Global Anthrax Vaccines Sales (M Doses), 2016-2021
Table 25. By Region - Global Anthrax Vaccines Sales (M Doses), 2022-2027
Table 26. By Country - North America Anthrax Vaccines Revenue, (US$, Mn), 2016-2021
Table 27. By Country - North America Anthrax Vaccines Revenue, (US$, Mn), 2022-2027
Table 28. By Country - North America Anthrax Vaccines Sales, (M Doses), 2016-2021
Table 29. By Country - North America Anthrax Vaccines Sales, (M Doses), 2022-2027
Table 30. By Country - Europe Anthrax Vaccines Revenue, (US$, Mn), 2016-2021
Table 31. By Country - Europe Anthrax Vaccines Revenue, (US$, Mn), 2022-2027
Table 32. By Country - Europe Anthrax Vaccines Sales, (M Doses), 2016-2021
Table 33. By Country - Europe Anthrax Vaccines Sales, (M Doses), 2022-2027
Table 34. By Region - Asia Anthrax Vaccines Revenue, (US$, Mn), 2016-2021
Table 35. By Region - Asia Anthrax Vaccines Revenue, (US$, Mn), 2022-2027
Table 36. By Region - Asia Anthrax Vaccines Sales, (M Doses), 2016-2021
Table 37. By Region - Asia Anthrax Vaccines Sales, (M Doses), 2022-2027
Table 38. By Country - South America Anthrax Vaccines Revenue, (US$, Mn), 2016-2021
Table 39. By Country - South America Anthrax Vaccines Revenue, (US$, Mn), 2022-2027
Table 40. By Country - South America Anthrax Vaccines Sales, (M Doses), 2016-2021
Table 41. By Country - South America Anthrax Vaccines Sales, (M Doses), 2022-2027
Table 42. By Country - Middle East & Africa Anthrax Vaccines Revenue, (US$, Mn), 2016-2021
Table 43. By Country - Middle East & Africa Anthrax Vaccines Revenue, (US$, Mn), 2022-2027
Table 44. By Country - Middle East & Africa Anthrax Vaccines Sales, (M Doses), 2016-2021
Table 45. By Country - Middle East & Africa Anthrax Vaccines Sales, (M Doses), 2022-2027
Table 46. Emergent BioSolutions Corporate Summary
Table 47. Emergent BioSolutions Anthrax Vaccines Product Offerings
Table 48. Emergent BioSolutions Anthrax Vaccines Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/K Doses) (2016-2021)
Table 49. Merial Corporate Summary
Table 50. Merial Anthrax Vaccines Product Offerings
Table 51. Merial Anthrax Vaccines Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/K Doses) (2016-2021)
Table 52. Merck Corporate Summary
Table 53. Merck Anthrax Vaccines Product Offerings
Table 54. Merck Anthrax Vaccines Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/K Doses) (2016-2021)
Table 55. Zoetis Corporate Summary
Table 56. Zoetis Anthrax Vaccines Product Offerings
Table 57. Zoetis Anthrax Vaccines Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/K Doses) (2016-2021)
Table 58. Bayer Sanidad Animal Corporate Summary
Table 59. Bayer Sanidad Animal Anthrax Vaccines Product Offerings
Table 60. Bayer Sanidad Animal Anthrax Vaccines Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/K Doses) (2016-2021)
Table 61. Colorado Serum Corporate Summary
Table 62. Colorado Serum Anthrax Vaccines Product Offerings
Table 63. Colorado Serum Anthrax Vaccines Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/K Doses) (2016-2021)
Table 64. PharmAthene Corporate Summary
Table 65. PharmAthene Anthrax Vaccines Product Offerings
Table 66. PharmAthene Anthrax Vaccines Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/K Doses) (2016-2021)
Table 67. Tiankang Corporate Summary
Table 68. Tiankang Anthrax Vaccines Product Offerings
Table 69. Tiankang Anthrax Vaccines Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/K Doses) (2016-2021)
Table 70. Biogénesis-Bago Corporate Summary
Table 71. Biogénesis-Bago Anthrax Vaccines Product Offerings
Table 72. Biogénesis-Bago Anthrax Vaccines Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/K Doses) (2016-2021)
Table 73. CAVAC Corporate Summary
Table 74. CAVAC Anthrax Vaccines Product Offerings
Table 75. CAVAC Anthrax Vaccines Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/K Doses) (2016-2021)
Table 76. Rosenbusch Corporate Summary
Table 77. Rosenbusch Anthrax Vaccines Product Offerings
Table 78. Rosenbusch Anthrax Vaccines Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/K Doses) (2016-2021)
Table 79. Agrovet Corporate Summary
Table 80. Agrovet Anthrax Vaccines Product Offerings
Table 81. Agrovet Anthrax Vaccines Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/K Doses) (2016-2021)
Table 82. Vecol Corporate Summary
Table 83. Vecol Anthrax Vaccines Product Offerings
Table 84. Vecol Anthrax Vaccines Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/K Doses) (2016-2021)
Table 85. CVCRI Corporate Summary
Table 86. CVCRI Anthrax Vaccines Product Offerings
Table 87. CVCRI Anthrax Vaccines Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/K Doses) (2016-2021)
Table 88. IVPM Corporate Summary
Table 89. IVPM Anthrax Vaccines Product Offerings
Table 90. IVPM Anthrax Vaccines Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/K Doses) (2016-2021)
Table 91. Prondil Corporate Summary
Table 92. Prondil Anthrax Vaccines Product Offerings
Table 93. Prondil Anthrax Vaccines Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/K Doses) (2016-2021)
Table 94. CDV Corporate Summary
Table 95. CDV Anthrax Vaccines Product Offerings
Table 96. CDV Anthrax Vaccines Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/K Doses) (2016-2021)
Table 97. Indian Immunologicals Corporate Summary
Table 98. Indian Immunologicals Anthrax Vaccines Product Offerings
Table 99. Indian Immunologicals Anthrax Vaccines Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/K Doses) (2016-2021)
Table 100. Botswana Vaccine Institute Corporate Summary
Table 101. Botswana Vaccine Institute Anthrax Vaccines Product Offerings
Table 102. Botswana Vaccine Institute Anthrax Vaccines Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/K Doses) (2016-2021)
Table 103. Ceva Santé Animale Corporate Summary
Table 104. Ceva Santé Animale Anthrax Vaccines Product Offerings
Table 105. Ceva Santé Animale Anthrax Vaccines Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/K Doses) (2016-2021)
Table 106. Intervac Corporate Summary
Table 107. Intervac Anthrax Vaccines Product Offerings
Table 108. Intervac Anthrax Vaccines Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/K Doses) (2016-2021)
Table 109. JOVAC Corporate Summary
Table 110. JOVAC Anthrax Vaccines Product Offerings
Table 111. JOVAC Anthrax Vaccines Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/K Doses) (2016-2021)
Table 112. Anthrax Vaccines Production Capacity (M Doses) of Key Manufacturers in Global Market, 2019-2021 (M Doses)
Table 113. Global Anthrax Vaccines Capacity Market Share of Key Manufacturers, 2019-2021
Table 114. Global Anthrax Vaccines Production by Region, 2016-2021 (M Doses)
Table 115. Global Anthrax Vaccines Production by Region, 2022-2027 (M Doses)
Table 116. Anthrax Vaccines Market Opportunities & Trends in Global Market
Table 117. Anthrax Vaccines Market Drivers in Global Market
Table 118. Anthrax Vaccines Market Restraints in Global Market
Table 119. Anthrax Vaccines Raw Materials
Table 120. Anthrax Vaccines Raw Materials Suppliers in Global Market
Table 121. Typical Anthrax Vaccines Downstream
Table 122. Anthrax Vaccines Downstream Clients in Global Market
Table 123. Anthrax Vaccines Distributors and Sales Agents in Global Market

List of Figures
Figure 1. Anthrax Vaccines Segment by Type
Figure 2. Anthrax Vaccines Segment by Application
Figure 3. Global Anthrax Vaccines Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Global Anthrax Vaccines Market Size: 2021 VS 2027 (US$, Mn)
Figure 6. Global Anthrax Vaccines Revenue, 2016-2027 (US$, Mn)
Figure 7. Anthrax Vaccines Sales in Global Market: 2016-2027 (M Doses)
Figure 8. The Top 3 and 5 Players Market Share by Anthrax Vaccines Revenue in 2020
Figure 9. By Type - Global Anthrax Vaccines Sales Market Share, 2016-2027
Figure 10. By Type - Global Anthrax Vaccines Revenue Market Share, 2016-2027
Figure 11. By Type - Global Anthrax Vaccines Price (USD/K Doses), 2016-2027
Figure 12. By Application - Global Anthrax Vaccines Sales Market Share, 2016-2027
Figure 13. By Application - Global Anthrax Vaccines Revenue Market Share, 2016-2027
Figure 14. By Application - Global Anthrax Vaccines Price (USD/K Doses), 2016-2027
Figure 15. By Region - Global Anthrax Vaccines Sales Market Share, 2016-2027
Figure 16. By Region - Global Anthrax Vaccines Revenue Market Share, 2016-2027
Figure 17. By Country - North America Anthrax Vaccines Revenue Market Share, 2016-2027
Figure 18. By Country - North America Anthrax Vaccines Sales Market Share, 2016-2027
Figure 19. US Anthrax Vaccines Revenue, (US$, Mn), 2016-2027
Figure 20. Canada Anthrax Vaccines Revenue, (US$, Mn), 2016-2027
Figure 21. Mexico Anthrax Vaccines Revenue, (US$, Mn), 2016-2027
Figure 22. By Country - Europe Anthrax Vaccines Revenue Market Share, 2016-2027
Figure 23. By Country - Europe Anthrax Vaccines Sales Market Share, 2016-2027
Figure 24. Germany Anthrax Vaccines Revenue, (US$, Mn), 2016-2027
Figure 25. France Anthrax Vaccines Revenue, (US$, Mn), 2016-2027
Figure 26. U.K. Anthrax Vaccines Revenue, (US$, Mn), 2016-2027
Figure 27. Italy Anthrax Vaccines Revenue, (US$, Mn), 2016-2027
Figure 28. Russia Anthrax Vaccines Revenue, (US$, Mn), 2016-2027
Figure 29. Nordic Countries Anthrax Vaccines Revenue, (US$, Mn), 2016-2027
Figure 30. Benelux Anthrax Vaccines Revenue, (US$, Mn), 2016-2027
Figure 31. By Region - Asia Anthrax Vaccines Revenue Market Share, 2016-2027
Figure 32. By Region - Asia Anthrax Vaccines Sales Market Share, 2016-2027
Figure 33. China Anthrax Vaccines Revenue, (US$, Mn), 2016-2027
Figure 34. Japan Anthrax Vaccines Revenue, (US$, Mn), 2016-2027
Figure 35. South Korea Anthrax Vaccines Revenue, (US$, Mn), 2016-2027
Figure 36. Southeast Asia Anthrax Vaccines Revenue, (US$, Mn), 2016-2027
Figure 37. India Anthrax Vaccines Revenue, (US$, Mn), 2016-2027
Figure 38. By Country - South America Anthrax Vaccines Revenue Market Share, 2016-2027
Figure 39. By Country - South America Anthrax Vaccines Sales Market Share, 2016-2027
Figure 40. Brazil Anthrax Vaccines Revenue, (US$, Mn), 2016-2027
Figure 41. Argentina Anthrax Vaccines Revenue, (US$, Mn), 2016-2027
Figure 42. By Country - Middle East & Africa Anthrax Vaccines Revenue Market Share, 2016-2027
Figure 43. By Country - Middle East & Africa Anthrax Vaccines Sales Market Share, 2016-2027
Figure 44. Turkey Anthrax Vaccines Revenue, (US$, Mn), 2016-2027
Figure 45. Israel Anthrax Vaccines Revenue, (US$, Mn), 2016-2027
Figure 46. Saudi Arabia Anthrax Vaccines Revenue, (US$, Mn), 2016-2027
Figure 47. UAE Anthrax Vaccines Revenue, (US$, Mn), 2016-2027
Figure 48. Global Anthrax Vaccines Production Capacity (M Doses), 2016-2027
Figure 49. The Percentage of Production Anthrax Vaccines by Region, 2020 VS 2027
Figure 50. Anthrax Vaccines Industry Value Chain
Figure 51. Marketing Channels

Report Title: Anthrax Vaccines Market - Global Outlook and Forecast 2021-2027


Your Details
Valid Invalid number

SELECT A FORMAT

ADD TO CART BUY NOW